UPDRS activity of daily living score as a marker of Parkinson's disease progression

Movement Disorders

Volumn 24, Issue 2, 2009, Pages 224-230

  Harrison, Madaline B ^a,c   Wylie, Scott A ^a   Frysinger, Robert C ^a   Patrie, James T ^b   Huss, Diane S ^b   Currie, Lillian J ^a   Wooten, G Frederick ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c Health System   (United States)

Author keywords

Disease progression; Parkinson's disease; UPDRS

Indexed keywords

LEVODOPA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DAILY LIFE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; FEMALE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; MOTOR PERFORMANCE; PARKINSON DISEASE; PRIORITY JOURNAL; PROGNOSIS; UNIFIED PARKINSON DISEASE RATING SCALE;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; AGED, 80 AND OVER; ANTIPARKINSON AGENTS; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEVODOPA; MALE; MIDDLE AGED; PARKINSON DISEASE; PSYCHOMOTOR PERFORMANCE; TREATMENT OUTCOME;

EID: 61649122372     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22335     Document Type: Article

References (9)

1. Fahn S, Elton R; the UPDRS Development Committee. Unified Pakinson Disease Rating Scale. In: Fahn S, Marsden CD, Calne D, Goldstein M, editors. Recent developments in PD, Vol. 2. Florham Park, NJ: Macmillan Healthcare Information; 1987. p 153-163.
2. Louis ED, Lynch T, Marder K, Fahn S. Reliability of patient completion of the historical section of the UPDRS. Mov Disord 1996;11:185-192.
3. Martinez-Martin P, Gil-Nagel A, Gracia LM. Unified Parkinson disease Rating Scale characteristics and structure. Mov Disord 1994;9:76-83.
4. Stebbins GT, Goetz CG. Factor structure of the Unified Parkinson Disease Rating Scale: motor examination section. Mov Disord 1998;13:633-636.
5. Goetz CG, Stebbins GT. Achieving interrater reliability in PD: utility of the Movement Disorder Society-owned teaching tape of the Unified PD Rating Scale. Ann Neurol 2003;54(Suppl 7):S40.
6. Goetz CG, Leurgans S, Raman R; and the Parkinson Study Group. Placebo-associated improvements in motor function: comparison of subjective and objective sections of the UPDRS in early Parkinson's disease. Mov Disord 2003;17:283-288.
7. Louis ED, Tang MX, Cote L, Alfaro B, Mejia H, Marder K. Progression of Parkinsonian signs in Parkinson Disease. Arch Neurol 1999;56:334-337.
8. Jankovic J, Kapadia AS. Functional decline in Parkinson disease. Arch Neurol 2001;58:1611-1615.
9. Hely MA, Morris JGL, Traficante R, Reid WGJ, O'Sullivan DJ, Williamson PM. The Sydney multicenter study of PD: progression and mortality at 10 years. J Neurol Neurosurg Psychiatr 1999;67:300-307.